UNIGE document Scientific Article
previous document  unige:20602  next document
add to browser collection

Hepatitis C virus controls interferon production through PKR activation

Arnaud, Noella
Dabo, Stephanie
Maillard, Patrick
Budkowska, Agata
Kalliampakou, Katerina I.
Mavromara, Penelope
Hugon, Jacques
show hidden authors show all authors [1 - 12]
Published in PloS one. 2010, vol. 5, no. 5, e10575
Abstract Hepatitis C virus is a poor inducer of interferon (IFN), although its structured viral RNA can bind the RNA helicase RIG-I, and activate the IFN-induction pathway. Low IFN induction has been attributed to HCV NS3/4A protease-mediated cleavage of the mitochondria-adapter MAVS. Here, we have investigated the early events of IFN induction upon HCV infection, using the cell-cultured HCV JFH1 strain and the new HCV-permissive hepatoma-derived Huh7.25.CD81 cell subclone. These cells depend on ectopic expression of the RIG-I ubiquitinating enzyme TRIM25 to induce IFN through the RIG-I/MAVS pathway. We observed induction of IFN during the first 12 hrs of HCV infection, after which a decline occurred which was more abrupt at the protein than at the RNA level, revealing a novel HCV-mediated control of IFN induction at the level of translation. The cellular protein kinase PKR is an important regulator of translation, through the phosphorylation of its substrate the eIF2alpha initiation factor. A comparison of the expression of luciferase placed under the control of an eIF2alpha-dependent (IRES(EMCV)) or independent (IRES(HCV)) RNA showed a specific HCV-mediated inhibition of eIF2alpha-dependent translation. We demonstrated that HCV infection triggers the phosphorylation of both PKR and eIF2alpha at 12 and 15 hrs post-infection. PKR silencing, as well as treatment with PKR pharmacological inhibitors, restored IFN induction in JFH1-infected cells, at least until 18 hrs post-infection, at which time a decrease in IFN expression could be attributed to NS3/4A-mediated MAVS cleavage. Importantly, both PKR silencing and PKR inhibitors led to inhibition of HCV yields in cells that express functional RIG-I/MAVS. In conclusion, here we provide the first evidence that HCV uses PKR to restrain its ability to induce IFN through the RIG-I/MAVS pathway. This opens up new possibilities to assay PKR chemical inhibitors for their potential to boost innate immunity in HCV infection.
Keywords Adaptor Proteins, Signal Transducing/metabolismCell Line, TumorEnzyme Activation/drug effectsEukaryotic Initiation Factor-2/metabolismHepacivirus/drug effects/*immunologyHepatitis C/immunology/virologyHumansInterferons/*biosynthesisKineticsModels, ImmunologicalPhosphorylation/drug effectsProtein BiosynthesisProtein Kinase Inhibitors/pharmacologySubstrate Specificity/drug effectsTime FactorsTranscription Factors/metabolismUbiquitin-Protein Ligases/metabolismEIF-2 Kinase/antagonists & inhibitors/*metabolism
PMID: 20485506
Full text
Research group Virologie moléculaire (275)
(ISO format)
ARNAUD, Noella et al. Hepatitis C virus controls interferon production through PKR activation. In: PloS one, 2010, vol. 5, n° 5, p. e10575. doi: 10.1371/journal.pone.0010575 https://archive-ouverte.unige.ch/unige:20602

551 hits



Deposited on : 2012-05-22

Export document
Format :
Citation style :